TY - JOUR
T1 - Differential impact of obesity on glucose metabolism in black and white American adolescents
AU - Schuster, Dara P.
AU - Kien, C. L.
AU - Osei, Kwame
N1 - Funding Information:
We wish to thank Mr. James Spiropoulos for technical assistance, The Core Laboratories of The Ohio State University, the nursing staff of the Clinical Research Center, the GCRC-RR-34, National Institutes of Health, Bethesda, MD, and Dr. R. R. Wolfe and his laboratory for help with the GCIMS analyses. A special thank-you to the Davis Scholarship Fund of The Ohio State University and the Central Ohio Diabetes Association for the grant support which helped to make this study possible.
PY - 1998/12
Y1 - 1998/12
N2 - Background: The authors have previously demonstrated abnormalities in glucose and insulin metabolism in nondiabetic black American (BA) adults versus white American (WA) adults. Whether similar glucoregulatory alterations extend to BA adolescents remain unknown. In addition, obesity, a known risk factor for insulin resistance and hyperinsulinemia, occurs in a greater proportion of BA adults and children when compared to WA. The objective of the present study was to examine the differential effects of obesity on glucose homeostasis in BA and WA adolescents. Methods: We examined glucose homeostasis in BA and WA adolescents using oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGTT), and [6,6-2H2]- glucose infusion. The study consisted of four age-, sex-, and pubertal stage- matched groups: 15 lean BA, 29 lean WA, 7 obese BA, and 9 obese WA. Results: Both obese groups had significantly increased insulin and C-peptide area under the curve (AUC) during OGTT and IVGTT when compared to their same-race lean counterparts. During OGTT, obese BA demonstrated greater insulin and C- peptide when compared to obese WA. During IVGTT, first-and second-phase insulin were significantly greater in obese BA versus obese WA. Conclusion: In summary, BA adolescents demonstrated insulin resistance which is markedly exaggerated in the face of obesity when compared to WA adolescents, implying a differential impact for obesity on glucose homeostasis that is unique to the obese BA adolescent group. In conclusion, there is a need for early aggressive weight management in obese BA adolescents.
AB - Background: The authors have previously demonstrated abnormalities in glucose and insulin metabolism in nondiabetic black American (BA) adults versus white American (WA) adults. Whether similar glucoregulatory alterations extend to BA adolescents remain unknown. In addition, obesity, a known risk factor for insulin resistance and hyperinsulinemia, occurs in a greater proportion of BA adults and children when compared to WA. The objective of the present study was to examine the differential effects of obesity on glucose homeostasis in BA and WA adolescents. Methods: We examined glucose homeostasis in BA and WA adolescents using oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGTT), and [6,6-2H2]- glucose infusion. The study consisted of four age-, sex-, and pubertal stage- matched groups: 15 lean BA, 29 lean WA, 7 obese BA, and 9 obese WA. Results: Both obese groups had significantly increased insulin and C-peptide area under the curve (AUC) during OGTT and IVGTT when compared to their same-race lean counterparts. During OGTT, obese BA demonstrated greater insulin and C- peptide when compared to obese WA. During IVGTT, first-and second-phase insulin were significantly greater in obese BA versus obese WA. Conclusion: In summary, BA adolescents demonstrated insulin resistance which is markedly exaggerated in the face of obesity when compared to WA adolescents, implying a differential impact for obesity on glucose homeostasis that is unique to the obese BA adolescent group. In conclusion, there is a need for early aggressive weight management in obese BA adolescents.
KW - Diabetes
KW - Hepatic glucose production
KW - Insulin
UR - https://www.scopus.com/pages/publications/0032430766
U2 - 10.1016/s0002-9629(15)40445-8
DO - 10.1016/s0002-9629(15)40445-8
M3 - Article
C2 - 9856689
AN - SCOPUS:0032430766
SN - 0002-9629
VL - 316
SP - 361
EP - 367
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 6
ER -